IANINA SUPONITSKY: Open Payments
NPI 1124407465 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,197 in 61 payments from 9 companies in 2025. Trend: 2023 $3,328 · 2024 $1,812 · 2025 $2,197
Food & beverage: $2,197
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 19 | $765 |
| Lundbeck LLC | 15 | $434 |
| E.R. Squibb & Sons, L.L.C. | 6 | $387 |
| Janssen Pharmaceuticals, Inc | 10 | $245 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $133 |
| Teva Pharmaceuticals USA, Inc. | 1 | $110 |
| Alkermes, Inc. | 3 | $69 |
| ABBVIE INC. | 1 | $29 |
| Luye Pharma (USA) Ltd. | 1 | $25 |
Products named: REXULTI, ABILIFY ASIMTUFII, COBENFY, INVEGA SUSTENNA, CAPLYTA, ABILIFY MAINTENA, AUSTEDO XR, LYBALVI.
Industry payments across NY — which companies pay providers there.
